A real-world retrospective study of omeprazole–domperidone combination in managing acid peptic disease with PRoton-pump Inhibitors in patients with type 2 DiabEtes mellitus (PRIDE-2)

BACKGROUND: Proton-pump inhibitors, along with a prokinetic agent, are widely used to provide symptomatic relief amongst patients with acid peptic disease (APD). This article evaluates the effectiveness and safety of the omeprazole–domperidone combination amongst patients with type 2 diabetes mellit...

Descripción completa

Detalles Bibliográficos
Autores principales: Saboo, Bharat, Mulwani, Nimmi, Petare, Anup Uttam, Veligandla, Krishna Chaitanya, Pinto, Colette Stephen, Mane, Amey, Rathod, Rahul, Kotak, Bhavesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933899/
https://www.ncbi.nlm.nih.gov/pubmed/36816461
http://dx.doi.org/10.7573/dic.2022-10-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933899/
https://www.ncbi.nlm.nih.gov/pubmed/36816461
http://dx.doi.org/10.7573/dic.2022-10-3

Ejemplares similares